MedTrace Logo

Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in Norway

NCT04381247 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2021-12-06

No results posted yet for this study

Summary

HVAPNOR consists of Three work packages:

1. Prospective observational study of Hospital (HAP) - and ventilator-Associated pneumonia (VAP) at 5 hospitals in Norway. Establish optimized routines for microbiological sampling, diagnostics and antibiotic stewardship..
2. Biomarker studies in HAP and VAP.
3. Studies on capacity building in HAP and VAP diagnostics.

Conditions

  • Pneumonia, Ventilator-Associated
  • Hospital-acquired Pneumonia
  • Infectious Disease
  • Infection, Hospital
  • Antibiotic Resistant Infection

Interventions

DIAGNOSTIC_TEST

Molecular diagnostics in HAP and VAP

Airway samples will be analyzed both by standard and molecular based microbiological analysis.

Sponsors & Collaborators

  • Haukeland University Hospital

    collaborator OTHER

  • University of Bergen

    collaborator OTHER

  • Vestre Viken Hospital Trust

    lead OTHER

Principal Investigators

  • Lars Heggelund, MD, PhD · Vestre Viken Hospital Trust

  • Harleen Grewal, MD, PhD · University of Bergen

  • Elling Ulvestad, MD, PhD · University of Bergen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2023-08-31
Completion
2024-12-31
FDA Device
Yes

Countries

  • Norway

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04381247 on ClinicalTrials.gov